Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Suberbielle-Boissel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pediatric Transplantation|January 14, 2017
Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in childrenL-M Petit, M Rabant, D Canioni, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Determinants of poor graft outcome in patients with antibody-mediated acute rejectionC Lefaucheur, D Nochy, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 29, 2007
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantationC Lefaucheur, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejectionC Lefaucheur, D Nochy, J Andrade, et al.
Contributions to Nephrology|November 13, 2008
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantationC Lefaucheur, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 5, 2016
Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody CharacteristicsA Roux, I Bendib Le Lan, S Holifanjaniaina, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pediatric Transplantation|January 14, 2017
Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in childrenL-M Petit, M Rabant, D Canioni, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Determinants of poor graft outcome in patients with antibody-mediated acute rejectionC Lefaucheur, D Nochy, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 29, 2007
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantationC Lefaucheur, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejectionC Lefaucheur, D Nochy, J Andrade, et al.
Contributions to Nephrology|November 13, 2008
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantationC Lefaucheur, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodiesR Sberro-Soussan, J Zuber, C Suberbielle-Boissel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodiesA Loupy, C Suberbielle-Boissel, G S Hill, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 5, 2016
Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody CharacteristicsA Roux, I Bendib Le Lan, S Holifanjaniaina, et al.
Pageof 1